VEON Delivers Strong Start to 2026 1Q26: Revenue +17.0%, EBITDA +17.7%, Digital Surges +57.7% to 25.2% of Total Revenue Dubai and New York, May 13, 2026 – VEON Ltd. (NASDAQ: VEON), a global digital operator, today announced strong financial and operating results for the first quarter ended March 31, 2026. Key Highlights – First Quarter 2026Total revenue increased 17.0% YoY to USD 1,201 million EBITDA rose 17.7% YoY to USD 517 million, with EBITDA margin expanding 20 bps to 43.0% Digital revenues1 grew 57.7% YoY to USD 303 million, representing 25.2% of Group revenue; digital EBITDA was USD 105 million (34.6% margin) Financial services revenues grew 41.0% YoY to USD 135 million. Equity free cash flow (after leases and licenses) reached USD 246 million, up 73.4% YoY Capex amounted to USD 138 million, with LTM capex intensity of 20.4% (15.8%...

KYIV, Ukraine and DUBAI, United Arab Emirates and NEW YORK, May 13, 2026 (GLOBE NEWSWIRE) — Kyivstar Group Ltd (“Kyivstar,” the “Group”) 1Q26 results highlightsTotal revenue increased 26.6% year-on-year (“YoY”) to USD 323 mn (31.3% YoY to UAH 13.9 bn). EBITDA rose 23.5% YoY to USD 173 mn (28.5% YoY to UAH 7.5 bn), with an EBITDA margin of 53.5%. Net profit for the quarter was USD 85 mn, with earnings per share of USD 0.37. Digital revenues grew 256.6% YoY to USD 67 mn (270.3% YoY to UAH 2.9 bn), representing 20.9% of total revenue. Digital EBITDA was USD 29 mn (42.7% margin). Multiplay customers rose 31.6% YoY to 8.1 mn, representing 39.6% of one-month-active mobile customers. Capital expenditures excluding licenses and ROU totaled USD 67 mn (UAH 2.9 bn), with LTM capex intensity of 29.9% (20.9% for 1Q26) reflecting continued...

GOUVERNEUR, N.Y., May 12, 2026 (GLOBE NEWSWIRE) — Titan Mining Corporation (NYSE-A:TII, TSX:TI), (“Titan” or the “Company”) an established zinc concentrate producer in upstate New York and the only end-to-end producer of natural flake graphite in the U.S., today reported strong financial and operating performance for the first quarter ended March 31, 2026. During the quarter, Titan delivered revenue growth, generated positive operating cash flow, commenced end-to-end domestic graphite shipments and advanced evaluation work related to potential germanium recovery from existing process streams. Natural flake graphite and germanium are critical minerals of significant priority to the U.S. Government, and Titan looks to become a key component of the U.S. minerals security supply chain. Q1 2026 HIGHLIGHTS(1)(2) Operating and Financial...

MINNEAPOLIS and BRISBANE, Australia, May 12, 2026 (GLOBE NEWSWIRE) — Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR) a global structural heart company committed to designing, developing, and commercializing cutting-edge medical devices to restore healthy heart function, today reported financial results for the quarter ended March 31, 2026, and provided a corporate update. Q1 2026 HighlightsCompleted aggregate capital raises totalling $320 million in January 2026 to support execution of the PARADIGM Trial and advance the Company toward global commercialization of the DurAVR® THV System Advanced PARADIGM Trial recruitment, supported by ongoing regulatory and operational work to activate additional countries and sites – post quarter-end, U.S. enrollment commenced Presented clinical data from...

Operations in Brazil and Seara helped offset an extremely challenging environment in the United States; Beef North America margin was -3.2% GREELEY, Colo., May 12, 2026 (GLOBE NEWSWIRE) — JBS reported net revenue of US$21.6 billion in 1Q26, an increase of 11% compared to 1Q25. Net income totaled US$221 million from January through March this year. The main drivers behind this performance were the operations of JBS Brazil, supported by strong global demand, and the consistent performance of Seara in both domestic and international markets. The results demonstrate the resilience of the Company’s global multi-protein and multi-geography strategy. The performance of operations in Brazil and the strength of other business units helped offset the challenges faced due to the North American cattle cycle. During the first quarter of 2026,...

CALGARY, Alberta, May 12, 2026 (GLOBE NEWSWIRE) — Peyto Exploration & Development Corp. (“Peyto” or the “Company”) (TSX: PEY) is pleased to report record operating and financial results for the first quarter of 2026, and a $0.01 per share (9%) increase to its monthly dividend. Q1 2026 Highlights:Peyto delivered record first quarter production volumes of 147,513 boe/d (777.6 MMcf/d of natural gas, 17,919 bbls/d of NGLs), a 10% increase year over year (7% on a per share basis), driven by the Company’s successful capital program. Reported its highest quarterly funds from operations1,2 (“FFO”) of $293.0 million ($1.41/diluted share), and generated $139.7 million of free funds flow3 in the quarter. Strong FFO was driven by the Company’s industry-leading low cash costs4 and realized natural...

EAF Unit 1 Fully Operational; Transition from Blast Furnace/Basic Oxygen Furnace to Electric Arc Furnace Steelmaking Complete Record Plate Sales of 116,000 NT with Further Upside Expected as Plate-First Strategy Scales Adjusted EBITDA in line with Previously Disclosed Guidance SAULT STE. MARIE, Ontario, May 12, 2026 (GLOBE NEWSWIRE) — Algoma Steel Group Inc. (NASDAQ: ASTL; TSX: ASTL) (“Algoma” or “the Company”), a leading Canadian producer of steel plate and hot rolled sheet products, today announced results for the three month period ended March 31, 2026. Unless otherwise specified, all amounts are in Canadian dollars. Business Highlights and First Quarter 2026 to First Quarter 2025 Comparisons Comparisons between Q1 2026 and Q1 2025 were significantly impacted by the transition from legacy blast furnace operations to the Company’s...

TORONTO, May 12, 2026 (GLOBE NEWSWIRE) — “The first quarter of 2026 was an important period for Dundee as it marked a meaningful step in the execution of our strategy,” said Jonathan Goodman, President and Chief Executive Officer of Dundee Corporation. “During the quarter, we closed an $85 million strategic partnership with Westhaven Gold Corp. to advance the Shovelnose Gold Project and the Spences Bridge Gold Belt. This transaction builds on Dundee’s long history as an active and engaged mining investor and represents a meaningful step toward deeper technical involvement, more direct project ownership, and potential future operatorship. In addition, we further strengthened our liquidity position through the sale of our net smelter royalty on the Borborema Gold Project.” “Our recently announced earn-in and joint-venture agreement...

ORLANDO, Fla., May 12, 2026 (GLOBE NEWSWIRE) — Gencor Industries, Inc. (the “Company” or “Gencor”) (NYSE American: GENC) hereby withdraws and retracts its press release dated May 8, 2026, titled “Gencor Industries, Inc. Releases Second Quarter Fiscal 2026 Results” (the “Prior Release”). The Prior Release was issued before the Company had completed its review of the Company’s financial statements for the quarter ended March 31, 2026 and should be disregarded in its entirety. Investors and other recipients should not rely on any information contained in the Prior Release, including the preliminary results of operations for the quarter ended March 31, 2026 reported therein. The Company cautions that no conclusions should be drawn from the Prior Release regarding the Company’s actual financial condition, results of operations, or business...

Robust response in highest dose cohort after 36 weeks following a single treatment of EP-104GI Completion of a $63.2 million public offering to enable clinical trials of EP-104GI in additional indications Well-capitalized into H2 2028, beyond key catalysts with over $140 million cash VANCOUVER, British Columbia, May 12, 2026 (GLOBE NEWSWIRE) — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (NASDAQ:EPRX) (TSX:EPRX), a clinical-stage biotechnology company leveraging its proprietary Diffusphere™ technology designed to optimize local, controlled drug delivery for applications with significant unmet need, today announced its financial results for the first quarter of 2026. “The clinical data reported this quarter further reinforces the potential for EP-104GI to become an important new...